Details for New Drug Application (NDA): 085320
✉ Email this page to a colleague
NDA 085320 describes CAM-METRAZINE, which is a drug marketed by Abc Holding, Camall, and Chartwell Rx, and is included in six NDAs. Additional details are available on the CAM-METRAZINE profile page.
The generic ingredient in CAM-METRAZINE is phendimetrazine tartrate. There are five drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.
The generic ingredient in CAM-METRAZINE is phendimetrazine tartrate. There are five drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.
Summary for 085320
| Tradename: | CAM-METRAZINE |
| Applicant: | Chartwell Rx |
| Ingredient: | phendimetrazine tartrate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 35MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
